We are live on ! Find out more
IART icon

Integra LifeSciences
IART

251 hedge funds and large institutions have $4.8B invested in Integra LifeSciences in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 92 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

40% more capital invested

Capital invested by funds: $3.43B → $4.8B (+$1.38B)

6% more funds holding

Funds holding: 237 → 251 (+14)

1.68% more ownership

Funds ownership: 86.29% → 87.97% (+1.7%)

10% less repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 92

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

37% less call options, than puts

Call options by funds: $2.61M | Put options by funds: $4.13M

Holders
251
Holders Change
+14
Holders Change %
+5.91%
% of All Funds
4.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
31
Increased
83
Reduced
92
Closed
15
Calls
$2.61M
Puts
$4.13M
Net Calls
-$1.52M
Net Calls Change
-$1.86M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$77.6M
2
EVM
Eaton Vance Management
Massachusetts
+$42.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$30.8M
4
CB
Cooke & Bieler
Pennsylvania
+$13.2M
5
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$11.1M

Top Sellers

1
Capital Research Global Investors
Capital Research Global Investors
California
-$38.9M
2
Brown Advisory
Brown Advisory
Maryland
-$24.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.7M
4
ECM
Endurant Capital Management
California
-$13.3M
5
Goldman Sachs
Goldman Sachs
New York
-$10.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
176
Janney Montgomery Scott
Pennsylvania
$370K +$24.4K +453 +9%
GT
177
Glenmede Trust
Pennsylvania
$367K -$44.3K -824 -13%
ZB
178
Zions Bancorporation
Utah
$363K +$21.5K +400 +8%
VIM
179
Vista Investment Management
Pennsylvania
$359K – – –
CT
180
Cambridge Trust
Massachusetts
$356K -$126K -2,337 -30%
BAM
181
Burgundy Asset Management
Ontario, Canada
$338K – – –
CCA
182
Conestoga Capital Advisors
Pennsylvania
$325K – – –
PA
183
Profund Advisors
Maryland
$319K -$65.3K -1,213 -20%
JMPWA
184
JP Morgan Private Wealth Advisors
California
$314K +$17.1K +317 +7%
Bessemer Group
185
Bessemer Group
New Jersey
$296K – – –
NIC
186
Northwest Investment Counselors
Oregon
$284K – – –
XM
187
XTX Markets
New York
$275K +$228K +4,237 New
MOS
188
MGO One Seven
Ohio
$271K +$225K +4,180 New
BC
189
Burney Company
Virginia
$267K +$221K +4,110 New
SLG
190
Stanley-Laman Group
Pennsylvania
$260K +$215K +4,000 New
AA
191
AQR Arbitrage
Connecticut
$259K +$215K +3,994 New
LIA
192
LS Investment Advisors
Michigan
$259K +$215K +3,995 New
SCM
193
Shelton Capital Management
Colorado
$257K -$18.4K -341 -8%
CS
194
Cannell & Spears
New York
$252K +$209K +3,880 New
CAPTRUST Financial Advisors
195
CAPTRUST Financial Advisors
North Carolina
$227K -$2.1K -39 -1%
CSS
196
Cubist Systematic Strategies
Connecticut
$227K +$188K +3,491 New
6M
197
6 Meridian
Kansas
$227K +$188K +3,497 New
WT
198
Whittier Trust
California
$217K – – –
CIBC Asset Management
199
CIBC Asset Management
Ontario, Canada
$216K +$179K +3,321 New
Mirae Asset Global Investments
200
Mirae Asset Global Investments
South Korea
$201K +$166K +3,094 New
6 7
8
9 10

IART Hedge Fund Activity: Q4 2020 in Review

251 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2020, worth a combined $4.8B — up 40% from $3.43B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new IART positions and 15 closed out — a net gain of 16 holders — while 83 added to existing stakes and 92 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $77.6M. The largest seller was Capital Research Global Investors, cutting an estimated $38.9M.

  • 251 institutional investors held Integra LifeSciences (IART) as of Q4 2020, up from 237 in Q3 2020.
  • Funds reported $4.8B of Integra LifeSciences stock for Q4 2020, up 40% quarter-over-quarter.
  • 31 funds opened new Integra LifeSciences positions in Q4 2020 and 15 closed out, a net change of +16 holders.
  • The largest Integra LifeSciences buyer in Q4 2020 was Wellington Management Group, an estimated $77.6M added.
  • The largest Integra LifeSciences seller in Q4 2020 was Capital Research Global Investors, an estimated $38.9M sold.

Based on aggregated 13F filings for Q4 2020.